Nakamura, T.; Takenaka, S.; Outani, H.; Hagi, T.; Tamiya, H.; Imura, Y.; Asanuma, K.; Sudo, A.
The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study. Cancers 2024, 16, 1077.
https://doi.org/10.3390/cancers16051077
AMA Style
Nakamura T, Takenaka S, Outani H, Hagi T, Tamiya H, Imura Y, Asanuma K, Sudo A.
The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study. Cancers. 2024; 16(5):1077.
https://doi.org/10.3390/cancers16051077
Chicago/Turabian Style
Nakamura, Tomoki, Satoshi Takenaka, Hidetatsu Outani, Tomohito Hagi, Hironari Tamiya, Yoshinori Imura, Kunihiro Asanuma, and Akihiro Sudo.
2024. "The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study" Cancers 16, no. 5: 1077.
https://doi.org/10.3390/cancers16051077
APA Style
Nakamura, T., Takenaka, S., Outani, H., Hagi, T., Tamiya, H., Imura, Y., Asanuma, K., & Sudo, A.
(2024). The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study. Cancers, 16(5), 1077.
https://doi.org/10.3390/cancers16051077
